Raúl Herzog
BMC Public Health · 2013
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Raúl Herzog trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Raúl Herzog's perspective
Ordered by how strongly the researchers Raúl Herzog trusts endorse each paper. Same corpus, a different order for every researcher.
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses (European Journal of Epidemiology)
- Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions (Annals of the Rheumatic Diseases)
- Evaluating non-randomised intervention studies. (Health Technology Assessment)
- Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. (Journal of the American Medical Association (JAMA))
- Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. (International Journal of Epidemiology)
- American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. (Circulation)
- Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. (Arthritis & Rheumatism)
- New therapies for treatment of rheumatoid arthritis. (The Lancet)
- Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. (The Lancet)
- Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. (American Journal of Medicine)